Your browser doesn't support javascript.
loading
Management of Atypical and Anaplastic Meningiomas.
Higgins, Dominique; Shah, Ashish H; Komotar, Ricardo J; Ivan, Michael E.
Afiliação
  • Higgins D; Department of Neurosurgery, University of North Carolina.
  • Shah AH; Department of Neurosurgery, University of Miami, University of Miami Brain Tumor Initiative.
  • Komotar RJ; Department of Neurosurgery, University of Miami, University of Miami Brain Tumor Initiative. Electronic address: RKomotar@med.miami.edu.
  • Ivan ME; Department of Neurosurgery, University of Miami, University of Miami Brain Tumor Initiative.
Neurosurg Clin N Am ; 34(3): 437-446, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37210132
ABSTRACT
Meningiomas are the most prevalent primary tumor of central nervous system origin, and although most of these neoplasms are benign, a small proportion exemplifies an aggressive profile characterized by high recurrence rates, pleomorphic histology, and overall resistance to standard treatment. Standard initial therapy for malignant meningiomas includes maximal safe surgical resection followed by focal radiation. The role for chemotherapy during recurrence of these aggressive meningiomas is less clear. Prognosis is poor, and recurrence of malignant meningiomas is high. This article provides an overview of atypical and anaplastic "malignant" meningiomas, their treatment, and ongoing research looking for more effective treatments.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article